CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate 
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
IRVINE, Calif., May 30, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC), today announced that Frank Grillo, CEO, will present at the LD Micro Invitational Conference on Wednesday, June 7, 2017, at 9:00 am Pacific Time. The event will be held at the Luxe Sunset Hotel in Bel Air, California.
Management will be available to meet with investors throughout the day. Investors wishing to schedule a meeting should contact LD Micro or MRI Interventions Investor Relations at [email protected].
About MRI Interventions, Inc.
Building on the imaging power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint® Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Contact Information: Matt Kreps, Darrow Associates Investor Relations Phone: (512) 696-6401 Email: [email protected]
